EATG ┬╗ News from The International Liver Congress 2018

News from The International Liver Congress 2018

The International Liver Congress™ 2018 (ILC 2018) is taking place from 11-15 April 2018 in Paris, France. It is an annual congress, organized by The European Association for the Study of the Liver (EASL), and attracts scientific and medical experts from around the world to learn about the latest in liver research.

******************

EASL: Italy: Ongoing hepatitis A virus outbreak among men who have sex with men is linked to current outbreaks in Europe

See also: Healio: Italian hepatitis A outbreak among MSM linked to two European strains

EASL: Screening for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis achieving sustained virological response is likely to be cost effective

EASL: Hepatitis E virus infections can be life threatening and transmitted through blood products

EASL: Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure

EASL: Linkage to care specialist facilitates access to hepatitis C treatment for people who inject drugs

******************

Healio: Real-world experience confirms Mavyret efficacy in HCV

Healio: Early-stage HCV treatment saves money, improves QOL

Healio: Health care costs increase by over 90% after compensated cirrhosis diagnosis

Healio: Cenicriviroc shows safe long-term antifibrotic activity in adults with NASH

— See also: infohep: Cenicriviroc treatment improves liver fibrosis in NASH patients

Healio: Multidrug-resistant infections increase mortality risk in cirrhosis

******************

hepinfo: Eight weeks of treatment with Epclusa cured almost all people receiving opioid substitution therapy

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn
News categories: Hepatitis